These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16258280)

  • 1. The mitotic checkpoint in cancer therapy.
    Tao W
    Cell Cycle; 2005 Nov; 4(11):1495-9. PubMed ID: 16258280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitosis and apoptosis: how is the balance set?
    Topham CH; Taylor SS
    Curr Opin Cell Biol; 2013 Dec; 25(6):780-5. PubMed ID: 23890995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
    Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
    Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death.
    Weaver BA; Cleveland DW
    Cancer Cell; 2005 Jul; 8(1):7-12. PubMed ID: 16023594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
    Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
    Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of mitotic slippage for antimicrotubule drug therapy.
    Cheng B; Crasta K
    Endocr Relat Cancer; 2017 Sep; 24(9):T97-T106. PubMed ID: 28684541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs.
    Schmidt M; Bastians H
    Drug Resist Updat; 2007; 10(4-5):162-81. PubMed ID: 17669681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.
    Dalton WB; Yang VW
    Future Oncol; 2009 Nov; 5(9):1363-70. PubMed ID: 19903065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mitosis for anti-cancer therapy.
    Sudakin V; Yen TJ
    BioDrugs; 2007; 21(4):225-33. PubMed ID: 17628120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotic checkpoint defects in human cancers and their implications to chemotherapy.
    Wang X; Cheung HW; Chun AC; Jin DY; Wong YC
    Front Biosci; 2008 Jan; 13():2103-14. PubMed ID: 17981695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy.
    Barillé-Nion S; Bah N; Véquaud E; Juin P
    Anticancer Res; 2012 Oct; 32(10):4225-33. PubMed ID: 23060542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle poisons and cell fate: a tale of two pathways.
    Matson DR; Stukenberg PT
    Mol Interv; 2011 Apr; 11(2):141-50. PubMed ID: 21540474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic drug targets.
    Kaestner P; Bastians H
    J Cell Biochem; 2010 Oct; 111(2):258-65. PubMed ID: 20518069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspases-dependent cleavage of mitotic checkpoint proteins in response to microtubule inhibitor.
    Baek KH; Shin HJ; Jeong SJ; Park JW; McKeon F; Lee CW; Kim CM
    Oncol Res; 2005; 15(3):161-8. PubMed ID: 16050137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-mitotic agents: Are they emerging molecules for cancer treatment?
    Penna LS; Henriques JAP; Bonatto D
    Pharmacol Ther; 2017 May; 173():67-82. PubMed ID: 28174095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
    Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB
    Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
    Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
    Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mitotic exit for cancer treatment.
    Wäsch R
    Expert Opin Ther Targets; 2011 Jul; 15(7):785-8. PubMed ID: 21476883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.
    Bekier ME; Fischbach R; Lee J; Taylor WR
    Mol Cancer Ther; 2009 Jun; 8(6):1646-54. PubMed ID: 19509263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of a functional spindle checkpoint for arsenite-induced apoptosis.
    Wu YC; Yen WY; Yih LH
    J Cell Biochem; 2008 Oct; 105(3):678-87. PubMed ID: 18668508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.